AIDS Weekly articles from September 2004

AIDS Weekly archives from September 2004

Systematic HAART for HIV patients with >500 T cell counts not supported by data.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The data does not support systematic highly active antiretroviral therapy for HIV patients with >500 T cell counts. "To assess the clinical, immunological and virological evolution in HIV-1...

False-negative syphilis test occurs in HIV infection due to prozone phenomenon.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- False-negative syphilis tests may occurs in HIV infection due to the prozone phenomenon. "The prozone phenomenon in syphilis testing refers to a false negative response resulting from overwhelming...

Immuno-PCR for HIV-1 p24 antigen lowers HIV-1 viral load detection limits.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- According to recent research published in the American Journal of Clinical Pathology, "Presently, the assay that attains maximal sensitivity and dynamic range of HIV-1 viral copy number (50 copies per...

Free antiretroviral therapy distributed to six most needy states in India.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Free antiretroviral therapy is being distributed to the six most needy states in India. According to recent research from the United States, "India has a population of more than 1 billion people....

Several factors serve as determinants of sensitivity to HIV fusion inhibitors.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Several factors serve as determinants of sensitivity to HIV fusion inhibitors. "C-peptides derived from the HIV envelope glycoprotein transmembrane subunit gp41 C-terminal heptad repeat (C-HR)...

Patient enrollment completed in phase I/II trial in AIDS.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Advanced Viral Research Corp. (ADVR) announced that all 30 patients have been enrolled in its phase I/II clinical trial of AVR118 in patients with AIDS, thereby completing patient enrollment in this...

Recombinant viruses and early global HIV-1 epidemic investigated.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Researchers report results of research on the early global HIV-1 epidemic in a recent issue of Emerging Infectious Diseases. "Central Africa was the epicenter of the HIV type 1 (HIV-1) pandemic....

Current CDC guidelines for HIV counseling, testing, and referral outlined.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- A researcher outlines the current Centers for Disease Control and Prevention (CDC) guidelines for HIV counseling, testing, and referral in a recent issue of the Annals of Emergency Medicine. ...

Folding and dimerization of HIV-1 protease yields evidence for stable monomer.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The folding and dimerization of HIV-1 protease have yielded evidence for a stable monomer from simulations. "HIV-1 protease (PR) is a major drug target in combating AIDS, as it plays a key role in...

HIV carrying D67N or K219Q/E mutation evolves to zidovudine resistance.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of...

Support utilization patterns of HIV-positive American Natives reported.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Investigators report health and support service utilization patterns of American Indians and Alaska Natives diagnosed with HIV/AIDS in a recent issue of AIDS Education and Prevention. "The purpose...

Candidate HIV type 1 vaccines elicit long-term memory B-cell responses.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Recipients of candidate human immunodeficiency virus type 1 vaccines exhibit long-term memory B-cell responses. "The efficacy and practical application of human immunodeficiency virus type I...

Codon optimization of HIV Tat enhance cell-mediated immune responses.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Codon optimization and ubiquitin conjugation of human immunodeficiency virus-1 Tat lead to enhanced cell-mediated immune responses. "The transactivator protein, Tat, is a potential candidate for...

Glycoprotein microarrays are useful tools in HIV glycobiology.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Oligosaccharide and glycoprotein microarrays are useful tools in HIV glycobiology. According to recent research from the United States, "Defining HIV envelope glycoprotein interactions with host...

HIV-1 Tat(1-72) protein-coated nanoparticles elicit strong immune responses.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- HIV-1 Tat(1-72) protein-coated nanoparticles generate strong T cell type-1 immune responses. "A significant emphasis has been placed on the development of adjuvants and/or delivery systems to...

Hemagglutinating virus protein induces immune response with HIV vaccine.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Hemagglutinating virus of Japan protein is efficient for induction of CD4+ T-cell response by a hepatitis B core particle-based HIV vaccine. "By using the hepatitis B core (HBc) protein gene as a...

Heterologous envelope immunogens contribute to AIDS vaccine protection.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys. According to recent research from the United States, "Because a strategy to elicit broadly neutralizing...

Multi-subtype gp160 DNA immunization induces neutralizing anti-HIV antibodies.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodies. "A highly desirable feature for an human immunodeficiency virus type 1 (HIV-1) vaccine is the ability to induce...

Novel AZT and D4T derivatives show efficacy against HIV.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Novel AZT and D4T derivatives show efficacy against HIV "Two series of new lipophilic phosphonoformate and phosphonoacetate derivatives of AZT and d4T were synthesized and evaluated as anti-HIV...

Novel drug approaches minimize development of HIV-1 resistance to NNRTIs.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Novel drug approaches minimize the development of HIV-1 resistance to non-nucleoside reverse transcriptase inhibitors. According to recent research published in the International Journal of...

Enterobacter cloacae emerging as a common pathogen in neonatal units.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Enterobacter cloacae is emerging as a common pathogen in neonatal units. According to published research from France, "In the first week of December 2002, three infants hospitalized in the neonatal...

Monitoring R-methadone plasma levels useful for adjusting drug dose.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Monitoring R-methadone plasma levels is useful for adjusting the methadone dose. "A capillary electrophoresis method was developed to detect interactions between methadone and anti-retroviral...

microRNAs quantitated using a modified Invader assay.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- microRNAs were quantitated using a modified Invader assay. According to a study from the United States, "The short lengths of microRNAs (miRNAs) present a significant challenge for detection and...

Fuzeon maker reports strong Q4 and year-end results.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Chronimed, Inc., (CHMD) reported record revenue and earnings for the fourth quarter and year ended July 2, 2004. Total reported company revenue for the 14-week quarter ending July 2, 2004 was a...

Pharmaceutical company reports second quarter, clinical development results.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Progenics Pharmaceuticals, Inc., (NASDAQ: PGNX) announced its results of operations for the second quarter ended June 30, 2004, and first half of 2004. The company also provided an update of its...

Formation of effector memory CD4+ cells necessary for recovery of CMV infection.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Formation of effector memory CD4+ cells is necessary for the recovery of cytomegalovirus infection. According to recent research published in the journal Human Immunology, "The correlates of...

New 3-minute rapid HIV test launched in the United States.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- MedMira Inc. (MedMira) (TSX Venture: MIR, NASDAQ:MMIRF) announced the U.S. launch of its newest U.S. Food and Drug Administration (FDA) approved rapid HIV test, the Reveal G2 Rapid HIV-1 Antibody Test...

Mutations conferring drug resistance partially resensitize resistant HIV to AZT.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Point mutations conferring drug resistance partially resensitize resistant HIV to AZT. According to recent research from France, "During zidovudine and stavudine treatment, HIV-1 selects several...

EBNA-2 gene variant may play role in pathogenesis of oral hairy leukoplakia.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- An EBNA-2 gene variant may play a role in the pathogenesis of oral hairy leukoplakia. A retrospective study from the United States "examined expression of Epstein-Barr virus (EBV) latent genes in...

New model can aid in understanding immune system diseases.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Researchers trying to understand diseases and develop new treatments can't always depend on existing tools or organisms to make discoveries; sometimes they first must create models of the problems they...

Emerging pharmaceutical company raises series D financing.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Pharmasset announced the completion of a US$40 million series D round of private equity financing led by Burrill & Company. New investor MDS Capital also provided significant participation in the...

Patient-applied home therapy attractive option for treatment of genital warts.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Patient-applied home therapy is an attractive option for the treatment of genital warts. According to a study from North Ireland, "Genital warts are one of the most commonly reported sexually...

Reveal Rapid HIV-1 Antibody Test No. 1 choice of U.S. hospitals, study shows.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- MedMira Inc. (MMIRF) announced that its Reveal Rapid HIV-1 Antibody Test is the number one choice of hospitals in the United States (where over 80% of HIV testing is conducted) according to a 2003 study...

Aerobic exercise dysfunction in HIV is potential link to physical disability.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Aerobic exercise dysfunction in HIV-infected persons is a potential link to physical disability. According to recent research published in the journal Physical Therapy, "Approximately 282,000...

Positive data reported for epitope-based HIV-1 vaccine.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Epimmune, Inc., (EPMN) announced the publication of data which showed that an epitope-based HIV-1 vaccine can be designed to induce cytotoxic T lymphocytes (CTL) capable of recognizing viruses from...

Resurgex nutritional formula beneficial for HIV patients on HAART therapy.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Resurgex, a patented multi-action, multi-component nutritional formula designed to address the comprehensive needs of individuals struggling with immuno-compromised conditions, was shown to have a...

South Africa: HIV+ women speak out.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- As part of the Women's Month celebrations in South Africa, a "Day of Hope" was held at Pinetown in KwaZulu-Natal province during August 2004 to tell the stories of three HIV positive women who are...

Zimbabwe: Activists fight traditional practices that increase women's HIV risk.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Traditional practices of polygamy, virginity testing, and "kugara nhaka," or wife inheritance, inhibit women's control over their bodies and increase vulnerability to HIV infection, but activists are...

HIV infections increasing in vulnerable areas of Cambodia.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- HIV infections are increasing in vulnerable areas of Cambodia. According to published research from the United States, "In the past decade, Cambodia has been experiencing the most serious HIV/AIDS...

Incidence of sexually transmitted diseases increasing in Philippines.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The incidence of sexually transmitted diseases is increasing in the Philippines. According to recent research published in the journal AIDS Education and Prevention, "HIV/AIDS has not yet caused a...

U.S. to withhold $120 million from AIDS fund unless other countries pay up.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The United States has challenged other countries to pay their share of the world's premier AIDS-fighting fund by the end of September or lose $120 million in U.S. cash. At issue is financing for...

Components of successful HIV/AIDS case management Alaskan villages identified.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The components of successful HIV/AIDS case management in Alaskan villages have been identified. "Case management is a valuable support service for HIV/AIDS patients, but little is known about the...

Dentist age/practice type associated with attitude towards HIV-infected patient.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Dentist age and practice type is associated with their attitude and care towards HIV-infected patients. "This paper derives from research conducted in the North West of England which was funded by...

Voluntary HIV testing in GUM clinic increased following education strategy.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Voluntary HIV testing in genitourinary medicine clinics increased following implementation of an education strategy. According to recent research published in the International Journal of STD and...

HIV infection increased 15% per year since 1997 in Taiwan.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- HIV infection has increased 15% per year since 1997 in Taiwan. According to a study from Taiwan, "The HIV/AIDS epidemic in Taiwan started in 1986, with 5,221 cases of HIV infections, 1,596 cases of...

HIV prevalence increasing in Indonesia.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- HIV prevalence is increasing in Indonesia. According to a study from Indonesia, "Until 1999 the known prevalence of HIV in Indonesia was low, except for isolated geographic groups exposed to Thai...

New HIV infections increasing among young men in Hong Kong.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- New HIV infections are increasing among young men in Hong Kong. "Hong Kong is an area with low HIV prevalence. Public health services provided through the methadone clinics and public sexually...

Boston Medical Center awarded $2.25 million to establish prevention program.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The Center for HIV/AIDS Care and Research (CHACR) at Boston Medical Center (BMC) has been awarded a $2.25 million, 5-year grant from the U.S. Centers for Disease Control and Prevention (CDC) to help...

HIV/hepatitis prevention urgently needed in drug treatment programs in Hungary.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- HIV and hepatitis prevention is urgently needed in drug treatment programs in Hungary. According to published research from the United States, "We assess HIV and hepatitis testing and counseling in...

Available evidence base for HIV/AIDS control in India is suboptimal.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The available evidence base for HIV/AIDS control in India is suboptimal. According to a study from India, "An optimum evidence base is necessary for the effective control of HIV/AIDS in India, as...

CXCR4 dimerization involved in SDF-1alpha- and gp120-induced signaling events.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- CXCR4 dimerization is involved in SDF-1alpha- and gp120-induced signaling events. "Both the chemokine SDF-1alpha and the human immunodeficiency virus-1 (HIV-1) coat protein gp120 can bind to CXCR4...

Filgrastim activates replication of minor variants of HIV-1.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Filgrastim activates the replication of minor variants of HIV-1. According to a study from the United States, "The hypothesis that filgrastim (r-met-huG-CSF) activates replication of minor variants...

HIV protease inhibitors are inhibitors but not substrates of BCRP/ABCG2.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- HIV protease inhibitors are inhibitors of but not substrates of the human breast cancer resistance protein (BCRP/ABCG2. According to published research from the United States, "Breast cancer...

HIV-1 promotes quiescence in human neural progenitor cells.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- HIV-1 promotes quiescence in human neural progenitor cells. "The exact mechanism by which human immunodeficiency virus type 1 (HIV-1) produces dementia remains obscure. We have recently found that...

Host factor Sam68 enhances HIV-1 RNA 3' end processing.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Host factor Sam68 enhances HIV-1 RNA 3' end processing. "Both cis elements and host cell proteins can significantly affect HIV-1 RNA processing and viral gene expression. Previously, we...

LNA/DNA chimeric oligomers mimic RNA aptamers targeted to HIV TAR RNA.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- LNA/DNA chimeric oligomers mimic RNA aptamers targeted to HIV TAR RNA. "One of the major limitations of the use of phosphodiester oligonucleotides in cells is their rapid degradation by nucleases....

AIDS infection increasing via heterosexual transmission in Malaysia.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- AIDS infection increasing via heterosexual transmission in Malaysia. According to a study from Malaysia, "Since the first case of HIV/AIDS was identified in 1986 in Malaysia, the number of infected...

Needle exchange has helped addicts for 10 years.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The nation's largest city-run exchange program for used intravenous drug needles has taken more than 6 million needles off the city's heroin-ravaged streets, according to the city's health commissioner....

Sex workers still a concern for HIV transmission in Singapore.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Sex workers are still a concern for HIV transmission in Singapore. According to a study from Singapore, "The first case of HIV infection in Singapore was reported in 1985. Between 1991 and 1998, the...

Low-income AIDS patients to get financial aid for drugs.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Help is on the way for more than 960 low-income North Carolinians with HIV who need money to pay for anti-viral drugs, state health officials said. The legislature recently appropriated $2.75...

Nigeria aims to spend $248 million providing HIV treatment to 200,000 sufferers.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Africa's most populous nation plans to spend $248 million on AIDS drugs for 200,000 HIV-infected Nigerians by the end of 2005, according to Health Minister Eyitayo Lambo. Aside from procuring the...

HAART improves outcome of HIV-associated plasmablastic lymphoma of oral cavity.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- "Plasmablastic lymphoma (PBL) is a recently described type of non-Hodgkin lymphoma (NHL) that occurs in up to 3% of patients with HIV infection. Although the clinical-pathological features of several...

Pneumocystosis still major health problem for HIV-positive and -negative patients.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Pneumocystosis is still a major health problem for HIV-positive and -negative patients. "In order to investigate the impact of Pneumocystis carinii infection in southern Spain following the...

Four resistance factors identified in interferon inhibitory activity.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Four resistance factors have been identified in interferon inhibitory activity. According to a study from the United States, "Interferon (IFN) resistance is an important factor in the...

Hepatocellular carcinomas likely to increase in HIV/HBV coinfected patients.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Hepatocellular carcinomas are likely to increase in HIV/HBV coinfected patients. According to recent research from the United States, "Infections with hepatitis B virus (HBV) and human...

Rural drinkers more likely to miss doses of HIV meds.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- People who live with HIV in rural areas are less likely to keep up with their treatment schedules if they are problem drinkers, say Tulane University researchers. Overall, about one in three...

Merger between Vitex and Panacos Pharmaceuticals endorsed.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- V.I. Technologies, Inc., (NASDAQ:VITX) (Vitex) announced that it has learned that Institutional Shareholder Services, Inc., (ISS) has recommended to its clients that they vote for the merger agreement...

Drug resistance mechanisms can reveal novel targets for antiretroviral agents.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Drug resistance mechanisms can reveal novel targets for antiretroviral agents. "HIV reverse transcriptase (RT) is the target of a number of important anti-AIDS drugs. Drugs that inhibit RT are...

Transporters play significant role in absorption and disposition of drugs.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Transporters play a significant role in the absorption and disposition of drugs. According to a study from the United States, "...in vitro and in vivo data were provided for saquinavir (SQV) showing...

Dispersing asylum seekers may increase HIV burden.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Doctors are concerned that the U.K. policy of dispersing asylum seekers may lead to increased HIV transmission, according to a new paper. More than 100,000 asylum seekers have so far been dispersed...

Patients prefer website-based strategy for sexual partner notification.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Patients prefer a website-based strategy for notification of sexual partners. According to a study from Australia, "This study was conducted to determine the estimated proportion of contactable...

STD care linked to provider sex, patient sex, high-risk behavior.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Variations in clinical care were associated with provider sex, patient sex, patients' self-reported symptoms or high-risk behaviors, and partner STD history. According to recent research published...

X marks the spot: Vector insertion is viral-specific.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Retroviruses are one of the most common vehicles for delivering therapeutic payloads via gene therapy in animal models of disease and human patients. Viruses integrate into host DNA to replicate, but...

Specific genotype correlates with high plasma efavirenz levels in HIV patients.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Specific genotype correlates with high plasma efavirenz levels in HIV patients on efavirenz-containing therapy. According to a study from Japan, "Efavirenz (EFV) is metabolized by cytochrome P450...

New guidelines maximize effects of occupational HIV post-exposure prophylaxis.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- New guidelines maximize the effects of occupational HIV post-exposure prophylaxis. "The European Commission funded a project for the standardization of the management of occupational exposures to...

HIV-1 evolution/immunological responses similar at 10 years despite therapies.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- HIV-1 evolution and immunological responses are similar after 10 years, despite various therapeutic strategies. "Two sexual partners infected with related HIV-1 viruses and enrolled in different...

Dynamics of HIV replication related to timing of ritonavir administration.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- The dynamics of HIV replication is related to the timing of ritonavir administration. According to recent research published in the Journal of Medical Virology, "Using a system that allows...

Non-drug-associated mutations different between plasma and vaginal HIV.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Non-drug-associated mutations are different between plasma and vaginal HIV. According to recent research from the United States, "There is increasing evidence that male or female genital tract...

Camelized VH intrabodies against vif neutralize HIV-1 infectivity.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Camelized rabbit-derived VH single-domain intrabodies against vif strongly neutralize HIV-1 infectivity. According to a study from Portugal, "We recently developed a specific single-chain antibody...

Prospects for an AIDS vaccine explored.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Researchers explore the prospects for an AIDS vaccine in a recent issue of Lancet Infectious Diseases. According to a study from the United States, "The unremitting devastation created by the AIDS...

Treatment among black, drug-using, HIV patients must be gender specific.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Black HIV infected women who use heroin present with different comorbidities than men, said researchers who advise, therefore, that drug-treatment programs be gender specific. "We examined gender...

Immunodeficiency model affects class switching to T-independent antigen.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- A new murine model of humoral immunodeficiency specifically affects class switching to T-independent antigens. According to recent research published in the European Journal of Immunology,...

Antifungal therapy still guided empirically due to lack of human data.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Antifungal therapy is still guided empirically due to the lack of human data. According to recent research published in the British Journal of Haematology, "The availability of new antifungal...

Extra copies of A. fumigatus squalene epoxidase gene confer resistance to terbinafine.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Extra copies of Aspergillus fumigatus squalene epoxidase gene confer resistance to TRB According to a study from the United States, "With the increasing use of antifungals such as amphotericin B,...